Cas:191419-07-5 2,3-Dichloro-5-methylpyridine manufacturer & supplier

We serve Chemical Name:2,3-Dichloro-5-methylpyridine CAS:191419-07-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2,3-Dichloro-5-methylpyridine

Chemical Name:2,3-Dichloro-5-methylpyridine
CAS.NO:191419-07-5
Synonyms:2,3-Dichloro-5-methylpyridine;2,3-Dichloro-4-picoline;2,3,5-TRIFLUORO-4-TRIFLUOROMETHYL-PHENYLAMINE;2,3-Dichloro-4-methylpyridine;Pyridine, 2,3-dichloro-5-methyl-;Pyridine,2,3-dichloro-4-methyl-(9CI);Pyridine, 2,3-dichloro-4-methyl-
Molecular Formula:C6H5Cl2N
Molecular Weight:162.017
HS Code:2933399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:224.8±35.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.547
PSA:12.89000
Exact Mass:160.979904
LogP:2.58

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2,3-Dichloro-5-methylpyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyridine, 2,3-dichloro-4-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-Dichloro-4-picoline Use and application,2,3,5-TRIFLUORO-4-TRIFLUOROMETHYL-PHENYLAMINE technical grade,usp/ep/jp grade.


Related News: After speaking to iRhythm on Tuesday, J.P. Morgan analysts wrote we shouldn’t expect an update on reimbursement before the release of the Physician Fee Schedule proposed rule in July/August. 2(3H)-Thiophenone,5-(4-chlorophenyl)-3-[(4-chlorophenyl)methyl]-3-(trifluoromethyl)- manufacturers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. Eicosanoic acid, 18-hydroperoxy- suppliers The Company’s Family 1 includes patent-pending compounds comprising two patent applications with priority dates of February 2020. 5,5′,5′-((benzene-1,3,5-triyltris(methylene))tris(oxy))triisophthaloyl dichloride vendor & factory.